IMCD NV (IMDZF)
151.44
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 8.620B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 0.12% |
| Valuation | |
| PE Ratio | 27.23 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.790 |
| Price to Book Value | 4.521 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 2.420 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6795 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 48.96% |
Profile
| IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment. |
| URL | https://www.imcdgroup.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Industrials |
| Industry | Trading Companies & Distributors |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | May. 16, 2024 |
| Last Ex-Dividend Date | Apr. 28, 2023 |
Ratings
Profile
| IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment. |
| URL | https://www.imcdgroup.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Industrials |
| Industry | Trading Companies & Distributors |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | May. 16, 2024 |
| Last Ex-Dividend Date | Apr. 28, 2023 |